None
Quote | Wuxi Biologics Cayman Inc ADR (OTCMKTS:WXXWY)
Last: | $2.775 |
---|---|
Change Percent: | 0.72% |
Open: | $2.76 |
Close: | $2.775 |
High: | $2.79 |
Low: | $2.76 |
Volume: | 36,714 |
Last Trade Date Time: | 07/23/2024 03:00:00 am |
News | Wuxi Biologics Cayman Inc ADR (OTCMKTS:WXXWY)
2024-07-16 01:12:48 ET Summary The good things to note about WXIBF is that the outlook for biotech funding is favorable, considering expectations of a rate cut this year, and the stock's potential buyback yield is appealing. The bad thing about WuXi Biologics is that the company's...
WuXi Biologics Named Constituent of the FTSE4Good Index Series for Fourth Year PR Newswire SHANGHAI , July 10, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), anno...
Message Board Posts | Wuxi Biologics Cayman Inc ADR (OTCMKTS:WXXWY)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Wuxi Biologics Cayman Inc ADR Company Name:
WXXWY Stock Symbol:
OTCMKTS Market:
WuXi Biologics Named Constituent of the FTSE4Good Index Series for Fourth Year PR Newswire SHANGHAI , July 10, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), anno...
WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of ~6 g/L/day at Pilot Scale PR Newswire By leveraging WuXiUP TM , WuXi Biologics has completed its first end-to-end continuous drug substance (DS) manufacturing ...
WuXi Biologics Receives AAA MSCI ESG Rating PR Newswire SHANGHAI , Nov. 7, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced it has received an AAA rating ...